IRADIMED Sees FY23 Revenue Of $65.0M-$65.5M Versus Consensus Of $64.77M And Prior Range Of $64.5M-$65.5M
Portfolio Pulse from Benzinga Newsdesk
IRADIMED has updated its FY23 revenue forecast to a range of $65.0M-$65.5M, which is higher than the consensus estimate of $64.77M and its previous range of $64.5M-$65.5M.
November 03, 2023 | 12:08 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
IRADIMED's updated FY23 revenue forecast is higher than both the consensus estimate and its previous range, which could positively impact its stock price.
Companies that raise their revenue forecasts typically see a positive reaction in their stock price as it indicates better-than-expected performance. Given that IRADIMED's new forecast is higher than the consensus estimate, it suggests that the company is performing well, which could lead to an increase in its stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100